Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment

PHASE3CompletedINTERVENTIONAL
Enrollment

572

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

March 31, 2010

Conditions
Type 2 Diabetes
Interventions
DRUG

Saxagliptin

2.5 mg once daily oral dose

DRUG

Placebo

Placebo

Trial Locations (74)

Unknown

Research Site, Concord

Research Site, Sacramento

Research Site, Denver

Research Site, Topeka

Research Site, Baltimore

Research Site, Great Falls

Research Site, Greenville

Research Site, Morehead City

Research Site, Cincinnati

Research Site, Corpus Christi

Research Site, Charleston

Research Site, Brest

Research Site, Homyel

Research Site, Minsk

Research Site, Dimitrovgrad

Research Site, Sofia

Research Site, Veliko Tarnovo

Research Site, Rijeka

Research Site, Karlovac

Research Site, Osijek

Research Site, Split

Research Site, Zagreb

Research Site, Moravský Krumlov

Research Site, Prague

Research Site, Teplice

Research Site, Ústí nad Labem

Research Site, Znojmo

Research Site, Tallinn

Research Site, Dieburg

Research Site, Düsseldorf

Research Site, Hanover

Research Site, Heidelberg

Research Site, Mannheim

Research Site, Debrecen

Research Site, Győr

Research Site, Kalocsa

Research Site, Kecskemét

Research Site, Zalaegerszeg

Research Site, Riga

Research Site, Kaunas

Research Site, Klaipėda

Research Site, Panevezys

Research Site, Vilnius

Research Site, Lodz

Research Site, Bialystok

Research Site, Ciechanów

Research Site, Golub-Dobrzyń

Research Site, Grodzisk Mazowiecki

Research Site, Katowice

Research Site, Krakow

Research Site, Maków Mazowiecki

Research Site, Radom

Research Site, Szczecin

Research Site, Warsaw

Research Site, Wroclaw

Research Site, Zabrze

Research Site, Bacau

Research Site, Brasov

Research Site, Satu Mare

Research Site, Bucharest

Research Site, Sf Gheorghe

Research Site, Chelyabinsk

Research Site, Moscow

Research Site, Ryazan

Research Site, Saint Petersburg

Research Site, Yaroslavl

Research Site, Dnipropetrovsk

Research Site, Ivano-Frankivsk

Research Site, Kharkiv

Research Site, Kyiv

Research Site, Mykolayiv

Research Site, Sumy

Research Site, Ternopil

Research Site, Zaporizhzhya

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

AstraZeneca

INDUSTRY